View in EDS

Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024.

Saved in:
Bibliographic Details
Title: Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024.
Authors: Manfrin A; Medicines and Healthcare Products Regulatory Agency, UK., Lee K; Medicines and Healthcare Products Regulatory Agency, UK., Cacou C; Medicines and Healthcare Products Regulatory Agency, UK., Pound J; Medicines and Healthcare Products Regulatory Agency, UK., Harnden A; Medicines and Healthcare Products Regulatory Agency, UK., Raine J; Medicines and Healthcare products Regulatory Agency (Retired), UK., Pirmohamed M; University of Liverpool, UK.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 Mar; Vol. 92 (3), pp. 822-829. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41047928
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Manfrin+A%22">Manfrin A</searchLink>; Medicines and Healthcare Products Regulatory Agency, UK.<br /><searchLink fieldCode="AU" term="%22Lee+K%22">Lee K</searchLink>; Medicines and Healthcare Products Regulatory Agency, UK.<br /><searchLink fieldCode="AU" term="%22Cacou+C%22">Cacou C</searchLink>; Medicines and Healthcare Products Regulatory Agency, UK.<br /><searchLink fieldCode="AU" term="%22Pound+J%22">Pound J</searchLink>; Medicines and Healthcare Products Regulatory Agency, UK.<br /><searchLink fieldCode="AU" term="%22Harnden+A%22">Harnden A</searchLink>; Medicines and Healthcare Products Regulatory Agency, UK.<br /><searchLink fieldCode="AU" term="%22Raine+J%22">Raine J</searchLink>; Medicines and Healthcare products Regulatory Agency (Retired), UK.<br /><searchLink fieldCode="AU" term="%22Pirmohamed+M%22">Pirmohamed M</searchLink>; University of Liverpool, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2026 Mar; Vol. 92 (3), pp. 822-829. <i>Date of Electronic Publication: </i>2025 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41047928
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/bcp.70308
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 822
    Titles:
      – TitleFull: Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Manfrin A
      – PersonEntity:
          Name:
            NameFull: Lee K
      – PersonEntity:
          Name:
            NameFull: Cacou C
      – PersonEntity:
          Name:
            NameFull: Pound J
      – PersonEntity:
          Name:
            NameFull: Harnden A
      – PersonEntity:
          Name:
            NameFull: Raine J
      – PersonEntity:
          Name:
            NameFull: Pirmohamed M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2125
          Numbering:
            – Type: volume
              Value: 92
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: British journal of clinical pharmacology
              Type: main
ResultId 1